AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MIAMI BEACH - Thrombocytosis is associated with more aggressive tumor biology in patients with epithelial ovarian cancer, according to a recent retrospective study.
That finding has immediate implications for the management of ovarian cancer patients with thrombocytosis. Specifically, because cancers are more likely to recur in patients with thrombocytosis, it is appropriate to individualize treatment and consider using experimental therapies in an effort to improve long-term survival in these patients, Dr. Andrew J. Li said in a poster presentation at the annual meeting of the Society of Gynecologic Oncologists.
The results could also lead to development of more targeted therapies, said Dr. Li of Cedars-Sinai Medical Center, Los Angeles.
In the study, 183 consecutive patients with invasive epithelial ovarian carcinoma or primary peritoneal carcinoma underwent ...
Source: HighBeam Research, Thrombocytosis linked to aggressive ovarian ca. (Cancer Recurrence...